Viridian Therapeutics, Inc.\DE

Invesco Ltd. VRDN
Report date
12/31/2025
Quarter
2025 Q4
Filed
2/19/2026
Shares
183,468
Value ($000)
5,710
Weight
0.0%
2022 Q2 - 2025 Q4 (15 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).